跳至主要内容
临床试验/NCT04173390
NCT04173390Unknown2 期

Preemptive Analgesia With Pregabalin in Heart Surgery: a Randomized Clinical Trial

InCor Heart Institute2 个研究点 分布在 1 个国家目标入组 230 人开始时间: 2021年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
230
试验地点
2
主要终点
Pain perception in visual analog scale (0 means no pain and 10 is the most severe pain) at 72 hour post operative

研究概览

简要总结

BACKGROUND: Postoperative pain after cardiac surgery has high incidence and is associated with worse morbidity. Pregabalin is a new antiepileptic drug used in patients with chronic pain and has been studied even more in postoperative. OBJECTIVE: Evaluate whether preemptive pregabalin use compared with placebo decreases pain perception in patients undergoing cardiac surgery in the first 24 hours and 2 months after hospital discharge; evaluate analgesic consumption in the immediate postoperative period; evaluate differences in blood gas parameters between groups; evaluate anesthetic recovery by QoR-40; assess incidence of serious adverse events (reintubation and mental confusion); incidence of delirium through the CAM-ICU questionnaire; assess adverse drug events (nausea, vomiting, pharmacodermia, allergic reactions). METHOD: Randomized, triple-blind, placebo-controlled clinical trial. EXPECTED RESULTS: Postoperative pain control with a drug that could cause fewer side effects, may lead to faster clinical improvement, fewer medications and fewer procedures, and lower healthcare costs with a decrease in intensive care unit (ICU) stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who will undergo median sternotomy due to the need for cardiac surgery (valvular or myocardial revascularization);
  • Patients between 18 and 70 years old;
  • Patients able to swallow tablets and agree to participate in this clinical trial.

排除标准

  • Patients with chronic renal failure with creatinine clearance less than or equal to 30 mL/min;
  • Patients with known hypersensitivity to pregabalin;
  • Hemodynamically unstable patients using vasoactive drugs the day before surgery;
  • Unconscious and/or sedated patients, or without cognitive discernment to use the visual analog scale;
  • Patients previously submitted to sternotomy; emergency surgery;
  • Patients with neurological diseases; anticonvulsant drug users.

研究组 & 干预措施

pregabalin

Experimental

干预措施: Pregabalin 150mg (Drug)

placebo

Placebo Comparator

干预措施: Placebo oral tablet (Drug)

结局指标

主要结局

Pain perception in visual analog scale (0 means no pain and 10 is the most severe pain) at 72 hour post operative

时间窗: 72 hours post operative

Analgesic opioids consumption at 72 hours post operative

时间窗: 72 hours post operative

次要结局

  • Pain perception in visual analog scale (0 means no pain and 10 is the most severe pain) and analgesic opioids consumption at month 2 post operative(Month 2 post operative)
  • Partial pressure of oxygen in millimeter of mercury (mmHg)(03 hours, 06 hours, 12 hours and 24 hours post operative)
  • Incidence of delirium by Confusion Assessed Method fo the Intensive Care Unity (CAM-ICU)(24 hour post operative)
  • Number of participants with treatment-related adverse drug events (nausea, vomiting, pharmacodermia, allergic reactions) assessed by Common Terminology Criteria for Adverse Events (CTCAE v5.0)(72 hour post operative)
  • Partial pressure of carbon dioxide in millimeter of mercury (mmHg)(03 hours, 06 hours, 12 hours and 24 hours post operative)
  • Arterial blood potential of hydrogen (pH)(03 hours, 06 hours, 12 hours and 24 hours post operative)
  • Oxygen saturation in percentage (%)(03 hours, 06 hours, 12 hours and 24 hours post operative)
  • Anesthetic recovery by Quality of Recovery 40-item questionnaire (QoR-40 - 40 items questionnaire each item ranging from 1 to 5 being 1 very poor and 5 excellent)(24 hour post operative)
  • Incidence of serious adverse events (reintubation, infection, bleeding, AKI)(72 hour post operative)

研究者

发起方
InCor Heart Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bruno Robalinho Cavalcanti Barbosa

Principal Investigator

InCor Heart Institute

研究点 (2)

Loading locations...

相似试验